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Abstract
Background: Gene synthesis is becoming an important tool in many fields of recombinant DNA technology,
including recombinant protein production. De novo gene synthesis is quickly replacing the classical cloning and
mutagenesis procedures and allows generating nucleic acids for which no template is available. In addition, when
coupled with efficient gene design algorithms that optimize codon usage, it leads to high levels of recombinant
protein expression.
Results: Here, we describe the development of an optimized gene synthesis platform that was applied to the large
scale production of small genes encoding venom peptides. This improved gene synthesis method uses a PCR-
based protocol to assemble synthetic DNA from pools of overlapping oligonucleotides and was developed to
synthesise multiples genes simultaneously. This technology incorporates an accurate, automated and cost effective
ligation independent cloning step to directly integrate the synthetic genes into an effective Escherichia coli
expression vector. The robustness of this technology to generate large libraries of dozens to thousands of synthetic
nucleic acids was demonstrated through the parallel and simultaneous synthesis of 96 genes encoding animal
toxins.
Conclusions: An automated platform was developed for the large-scale synthesis of small genes encoding
eukaryotic toxins. Large scale recombinant expression of synthetic genes encoding eukaryotic toxins will allow
exploring the extraordinary potency and pharmacological diversity of animal venoms, an increasingly valuable but
unexplored source of lead molecules for drug discovery.
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Background
Synthetic biology, an interdisciplinary branch of biology,
is quickly becoming one of the most attractive areas of
research thanks to the recent developments in gene
synthesis technology. In combination with intelligent
gene design, gene synthesis is emerging as a valuable
tool to support recombinant protein expression. De novo
gene design allows optimizing codon usage to the
recombinant host system thus promoting the effective
operation of the cellular translational machinery. In
addition, in cases where the nucleic acid template is not
available, gene synthesis allows creating DNA molecules
de novo. The exponential growth of genomic and meta-
genomic databases and the current limitations in using
this highly useful sequence information due to the lack
of tangible DNA are promoting the rapid development
of novel gene synthesis technologies.
In recent years, a variety of gene synthesis methodolo-
gies have been developed based on the assembling of
oligonucleotides into complete genes. Early approaches
advanced to synthesize nucleic acids used the enzymatic
ligation of pre-formed duplexes of phosphorylated
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overlapping oligonucleotides [1]. Subsequently, self-
priming PCR [2], PCR assembly [3], Polymerase chain
assembly (PCA) [4] and template-directed ligation [5]
were described as efficient concepts for de novo gene
synthesis of nucleic acids. Recently, methods based on a
two-step approach were reported for the production of
long DNA sequences. Examples of these technologies
are the PCR-based thermodynamically balanced inside-
out technology (TBIO) [6], the two-step total gene
synthesis method [7] that combines both dual asymmet-
rical PCR (DA-PCR) and overlap-extension (OE-PCR),
the PCR-based two-step DNA synthesis (PTDS) [8] and
PCR-based accurate synthesis (PAS) [9].
Lately, improvements in PCR-based gene synthesis
methods, as exemplified by the development of the
improved PCR synthesis (IPS) and the simplified gene
synthesis (SGS) protocols [8, 9], have been described
and incorporate significant simplifications over earlier
strategies. SGS uses oligonucleotides of 40 nucleotides
(nt) in length and 18–20 nt of overlap region, which are
assembled in a unique PCR-assembly reaction leading to
the direct construction of the full-length DNA molecule.
The simplicity of this protocol combined with its relative
low cost, since there no requirement for phosphorylation
or purification of the oligonucleotides exists, are a solid
base for the development of even more effective PCR-
based methods. However, major drawbacks persist and
effective improvements need to be implemented in
current synthetic protocols to allow their translation to a
large scale. One of the major bottlenecks of current gene
synthesis protocols consists on the quality of the oligo-
nucleotides used for nucleic acid assembly. It is known
that all current gene synthesis methods accumulate
errors in the final synthetic molecules. Sequence errors
usually derive from the incorporation of imperfect
synthetic oligonucleotides or result from low fidelity
rates associated with the enzymatic assembling step.
Current oligonucleotide synthesis methods produce
sequences that are often prematurely terminated, or
comprise internal mutations (error rates range from 1 to
10 mutation per kilobase (kb)) [10]. In addition, chem-
ical synthesis of DNA molecules usually not only involve
moderate to high error rates but also high costs. More-
over, the chemical synthesis of a desired gene also
depends on the accuracy of the DNA polymerase used
to assemble the oligonucleotides in a final DNA
sequence. Therefore, DNA errors are inevitable and it is
often necessary to remove the incorrect synthetic DNA
molecules using enzymatic methods [11, 12]. Improve-
ments in oligonucleotide quality, error correction and
DNA polymerase efficacy are thus urgently required.
Conventionally, PCR-based gene synthesis is employed
to produce a single gene at a time. Thus, development
of automated platforms that effectively generate large
libraries of nucleic acids is urgently needed. The differ-
ent steps leading to a single PCR-assembly strategy need
to remain simple, accurate and robust when extended to
the assembly of multiple genes simultaneously. To
develop large scale methods, many factors that affect the
efficiency of gene assembly, such as DNA polymerases
performance or oligonucleotide concentration and qual-
ity require optimization. This work describes different
approaches carried out to optimize current gene synthe-
sis protocols. The data was integrated to develop a novel
platform which was applied to efficiently synthesize and
clone a large number of nucleic acids encoding venom
peptides. This automated platform can be translated to
the rapid generation of complex gene libraries encoding
different families of biotechnologically relevant and valu-
able proteins and peptides.
Methods
Gene design
The original purpose of this research was to optimize
protocols for the synthesis of small genes encoding
eukaryotic peptides for expression in Escherichia coli.
Three genes of different lengths (A: 290 bp, B: 260 bp,
and C: 329 bp) were selected to develop these studies.
Gene A encodes the alpha-elapitoxin-Nk2a toxic protein
isolated from the Naja kaouthia venom, and genes B
and C encode two different venom peptides of unknown
function. Venom genes were designed by back-
translating the peptide sequence and optimizing codon
usage for high levels of expression in E. coli. Guanine-
cytosine (GC) content was set to vary between 40 and
60%. Gene design maximized stable mRNA molecules,
minimized the presence of repeated sequences and
avoided the appearance of E. coli regulatory sequences
such as promoters, activators or operators. In addition,
Codon Adaptation Index (CAI) value was set to be
higher than 0.8. DNA sequences of the three genes are
presented in Additional file 1: Table S1.
Oligonucleotides and purification
Oligonucleotides were synthesized by three different
suppliers (A, B and C) using the smaller scale available
with standard desalting. Reverse-phase cartridge and
reverse-phase HPLC purifications were also tested for
oligonucleotides obtained from supplier C. Each oligo-
nucleotide was reconstituted in 10 mM Tris-HCl
(pH 8.5) to a 100 μM final concentration and kept at
−20 °C. Oligonucleotides were used individually or in
mixtures at concentrations described below.
Primer design
The DNA sequence of each gene was used as a template
to design the assembly oligonucleotides by dividing the
entire sequence into overlapping primers with defined
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lengths. The external oligonucleotides, termed outer
primers, correspond to the external forward and reverse
primers. For strategy A (see below), the outer primers
include a complementary sequence of 15 bp to promote
plasmid re-circulation through homologous recombin-
ation (Fig. 1a). In strategy B (see below) the outer
primers contained an additional sequence at the 5’-
terminus of both forward and reverse primers for
Fig. 1 Schematic diagram representing the two different approaches used for gene synthesis: a. Polymerase chain assembly using DNA template
(PCA-DT), and b. Polymerase chain assembly DNA template-free (PCA-DTF). Each oligonucleotide is represented as an arrow; black arrows correspond
to internal (inner) oligonucleotides while external (outer) oligonucleotides are denoted as orange arrows. Each strand of the desired gene is dissected
into two or more oligonucleotides that are amplified (A) or overlap extended (b) by a DNA polymerase. A1-Two long oligonucleotides were designed
with a 20 bp overlap region with the cloning vector; A2-Two sets of 40-mer oligonucleotides containing the 5’-end and 3’-end sequences of the
desired gene were assembled by PCR; A3 – Successive oligonucleotides with 40 nt in length were designed with a 20 nt overlaps regions between
adjacent oligonucleotides to construct the full-length of cloning vector containing the desired gene. The PCR products from A1, A2 and A3 strategies
were inserted in E. coli cells through homologous recombination. Strategy B corresponds to a single-step PCR assembly step that does not require
template DNA. B1 – Gapless 40-mer oligonucleotides containing 20 nt overlap regions between primers were used to assemble the synthetic gene; B2
– 40-mer oligonucleotides with 15 bp overlaps between forward and reverse primers, with gaps of 10 nt were mixed to produce the gene of interest;
B3 – The synthetic gene was synthesized by mixing a 60-mer overlapping oligonucleotides containing gaps of 20 nt. After overlap extension by DNA
polymerase, gene fragments from B1, B2 and B3 were cloned into a vector using a ligation-independent cloning method. All outer primers contain a
vector complementary region at the 5’-end (highlighted in orange rectangles) or a 16 bp complementary sequence (highlighted in blue rectangles) to
facilitate the cloning reaction
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cloning into the cloning vector through a Ligation-
Independent Cloning protocol (LIC) (Fig. 1b). Internal
oligonucleotides (termed inner primers) are used in
higher numbers than outer primers. Depending on the
gene assembly strategy used, the oligonucleotides were
designed with gaps between adjacent primers and com-
prising 15–20 bp overlap regions. The sequence of all
oligonucleotides used in these studies are displayed in
Additional file 2: Table S2.
Novel strategies to synthesize small genes
In order to develop an efficient, cost-effective and low
error rate strategy to produce synthetic genes with
reduced size, two different strategies to construct opti-
mized DNA sequences were initially explored: (A) Poly-
merase chain assembly using DNA template (PCA-DT)
and (B) Polymerase chain assembly DNA template-free
(PCA-DTF) (Fig. 1a and b, respectively). PCA-DT was
developed to decrease the time involved in traditional
gene synthesis methods since this method combines
both synthesis and cloning in a single reaction. In step 1,
two long (A1) or a pool of small oligonucleotides con-
taining the gene sequence (A2 and A3) were mixed with
the cloning vector and then assembly proceeds using a
DNA polymerase in a typical cyclic temperature reaction
(Fig. 1a) (Table 1). In step 2, the product of the PCR
amplification combining both the newly synthesized
gene and the vector were used to transform E. coli cells.
PCA-DTF strategy is based on previously reported
methods used to produce synthetic genes in a single
PCR reaction [4, 9, 11]. All oligonucleotides (inner and
outer) were pooled together and assembled in a single
polymerase chain reaction. The outer primers were used
in a higher concentration than inner primers to ensure
the construction of full-length sequence of synthetic gene.
Different approaches for oligonucleotide design were
tested (Fig. 1, B1, B2 and B3). The PCA-DTF method re-
quires a subsequent ligation-free cloning step to insert the
synthetic gene into the cloning vector.
(A)PCA-DT
Three different strategies based on PCA-DT method
were used to synthesize gene A (290 nt). Two, fourteen
and twelve oligonucleotides were designed to
synthesize full-length gene A following strategies A1,
A2 and A3, respectively. For A1 strategy, the gene
sequence was dissected in two long oligonucleotides of
135 nt, including a 20 nt overlap with the cloning
vector. To produce the synthetic gene using A2
strategy, fourteen oligonucleotides of 20–40 nt with a
20 bp overlap region between forward and reverse
primers and no gaps between adjacent oligonucleotides
were designed. The length of twelve oligonucleotides
used in A3 was 35–40 nt and the overlapping
region between successive oligonucleotides was 20
bases. All outer primers contained an additional
15-bp homologous sequence to facilitate the
homologous recombination reaction associated
with E. coli transformation. Plasmid pNZY28 was
used as a cloning vector and was linearized with
EcoR V restriction enzyme during 2 h at 37 °C in
a heating block. A typical digestion was performed in
100 μL containing 2 μg of plasmid DNA and 50 units
of EcoR V restriction enzyme. Linear plasmid DNA was
purified using silica-based columns, eluted in 50 μL
elution buffer and diluted to a final concentration of
20 ng/ μL. The synthesis of gene A using the strategy
A1 was initiated with the addition of the two outer
primers at a final concentration of 200 nM to 20 ng of
digested pNZY28 vector. For strategies A2 and A3,
outer and inner primers were used at a final 800 nM
and 30 nM concentration, respectively. The PCR
reaction was carried out with 200 μM dNTPs and 2.5
units of Pfu Turbo DNA polymerase (Agilent
Technologies). The PCR conditions were 30 cycles
at 95 °C for 50 s, 50 °C for 50 s and 72 °C for 3 min.
The final cycle was followed by an additional 10 min
at 72 °C to ensure complete extension of the 3,099 bp
gene product (pUC18: 2,886 bp + gene A: 213 bp).
PCR amplification products were analysed by agarose
gel electrophoresis.
(B) PCA-FDT
To synthesize gene A based on strategies B1 and B2
of PCA-DTF, fourteen and twelve oligonucleotides
with 40 nt in length and 15 or 20 nt end-overlaps
between consecutive oligonucleotides, respectively,
Table 1 Gene assembly strategies using for production of the synthetic gene A
Gene assembly method DNA template Number of primers Primer size (nt) Cloning method
PCA-DT_A1 yes 2 135 Homologous recombination
PCA-DT_A2 yes 13 27–40 Homologous recombination
PCA-DT_A3 yes 12 35–40 Homologous recombination
PCA-DTF_B1 no 14 35–40 Gateway system
PCA-DTF_B2 no 12 30–40 Gateway system
PCA-DTF_B3 no 8 35–60 Gateway system
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were designed (Fig. 1, B1 and B2). Strategy B3 used
larger oligonucleotides with 60 nt including 20 nt
overlaps (Fig. 1, B3). Outer primers include an
additional ligation independent sequence (27 nt on
the forward primer and 32 nt on the reverse primer),
in order to allow ligation-independent cloning and a
18 bp encoding the Tobacco Etch Virus (TEV) pro-
tease. Oligonucleotide assembly was performed as
described above using Pfu Turbo DNA polymerase.
Assembly reaction was subjected to one cycle of
initial denaturation at 95 °C for 5 min, followed by
26 cycles of denaturation at 95 °C for 30 s; annealing
at 55 °C for 30 s; and extension at 72 °C for 30 s.
PCR amplification products were column purified, as
described above, and cloned into pDONR201 vector
using Gateway technology (see below).
Optimization of PCR conditions for successful gene
synthesis protocol
Efficacy and accuracy of DNA polymerases and the qual-
ity and concentration of primers are two critical parame-
ters known to influence gene synthesis. In addition,
annealing temperatures and times used for denaturation,
annealing and extension during PCR may affect nucleic
acid yields. To optimize these parameters, two genes (B
and C) were synthesised using gene synthesis strategy
B3. Six and eight oligonucleotides with 58–60 nt and a
20 bp gap between primers were used to synthesise
genes B and C, respectively. The sequences of overlap-
ping oligonucleotides used to produce genes B and C are
presented in Additional file 3: Table S3. The effect of
each PCR parameter was singly tested and the remaining
components of PCR reaction were fixed in the standard
conditions described above. Four DNA polymerases
were selected for these studies: KOD Hot Start DNA
polymerase (EMD-Millipore), Q5® Hot Star High Fidelity
DNA polymerase (New England Biolabs), Pfu Turbo
DNA polymerase (Agilent Technologies) and Taq DNA
polymerase (Sigma-Aldrich). PCR was developed in a
26-cycle reaction. Denaturation was performed at 95 °C
for 30 s for Pfu Turbo and Taq, 95 °C for 16 s for KOD
Hot Start DNA polymerase and 98 °C for 10 s for Q5®
Hot Star High Fidelity DNA polymerase. Annealing oc-
curred at 60 °C for 10 s for KOD Hot Start DNA poly-
merase and 60 °C for 30 s for Q5® Hot Star High Fidelity
DNA polymerase, Pfu Turbo and Taq. Finally, extension
was performed at 70 °C for 3 s for KOD Hot Start DNA
polymerase, 72 °C for 30 s for Pfu Turbo and Taq, and
72 °C for 15 s for Q5® Hot Star High Fidelity DNA poly-
merase. Different overlapping oligonucleotide concentra-
tions were tested. Gene assembly was performed using
inner oligonucleotides at a final concentration of 10, 20
and 30 nM. Outer primers were used at final concentra-
tions of 200, 600, 800 and 1000 nM. In addition, the final
concentration of dNTPs was set to vary between 0.1 and
0.5 mM. Finally, different PCR profiles were tested. Thus,
PCRs were performed at five different annealing tempera-
tures (from 50 °C to 62 °C). Furthermore, a total of
24 PCR programs, which included different times of
denaturation, annealing and extension in a total of
22, 24 and 26 cycles, were tested. Final configuration
of each PCR program used in these studies is pre-
sented in Additional file 4: Table S4.
Cloning and sequencing
After PCR assembly, resulting nucleic acids were purified,
inserted into a suitable vector and the integrity of each
gene was confirmed by DNA sanger sequencing. Synthe-
sized genes produced by strategy A were ligated into
pNZY28 cloning plasmid using the homologous recom-
bination machinery present in E. coli cells. Gene products
from strategies B1, B2 and B3 which contained attb1 and
attb2 sequences at its 5’ and 3’- ends, respectively, were
cloned into pDONR201 vector (ThermoFisher Scientific)
using the Gateway cloning system (ThermoFisher Scien-
tific). Cloning reaction mixtures were used to transform E.
coli DH5α competent cells. For each transformation, one
bacterial colony was inoculated and grown in liquid LB
medium supplemented with 100 μg/mL of ampicillin.
Plasmids were purified and recombinant integrity of
inserted nucleic acids confirmed by sequencing.
Construction of a novel gene synthesis platform for the
large scale production of small synthetic genes
An integrated gene synthesis platform was developed for
the efficient production of small synthetic genes. This
platform combines automation, simplicity and robustness,
while decreasing the error rate associated with conven-
tional gene synthesis methods. Initial experiments de-
scribed above defined the most appropriate PCR assembly
protocol. Subsequent experiments evaluated the efficacy
of the protocol when applied for the simultaneously syn-
thesis of 96 genes encoding venom peptides. Ninety six
genes were designed by back-translating corresponding
peptide sequences and by optimizing codon usage for high
levels of expression in E. coli. Codons were selected ran-
domly using a Monte Carlo approach according to E. coli
codon usage of highly expressed genes. Genes were de-
signed to have a GC content between 40 and 60% and a
codon adaptation index (CAI) value higher than 0.8. The
sequences of the 96 optimized genes are presented in
Additional file 5: Table S5. The pool of primers required
to synthesize 96 synthetic genes encoding venom peptides
were designed to have 50–60 nt in length, an overlap re-
gion of 20 nt between forward and reverse primers with a
gap sequence of 20 nt, and included an additional 16-bp
conserved sequences at 5’- terminus of both forward and
reverse outer primers to allow ligation-independent
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cloning. The 96 genes were produced from 96 mixes of six
oligonucleotides with 50–60 nt in length and 20 nt over-
laps. Oligonucleotides were synthesised by Integrated
DNA Technologies at the smallest scale (primer solutions
at 5 μM) with desalting purification. The two outer
primers were used at a final concentration of 800 nM
while the inner primers were pooled together in an equi-
molar mixture to achieve the final concentration of 20
nM. Primer dilutions and PCR assembly was carried out
in a 96-well plate format using a Tecan workstation
(Switzerland). KOD Hot Start DNA polymerase (EMD
Millipore) was used for PCR assembly using optimized
conditions to minimize primer-dimer formation and non-
specific amplifications. PCR reactions were performed in a
50 μL total volume and consisted of 0.2 mM dNTPs,
1.5 mM MgCl2, 1× reaction buffer and 1 unit of KOD Hot
Start DNA polymerase. PCR assembly reactions were car-
ried out in a 96-well PCR plate format. The cycling pa-
rameters were as follows: 1 cycle of 95 °C for 2 min;
26 cycles of 95 °C for 20 s, 60 °C for 8 s, and 70 °C for 3 s.
After PCR assembly, assembled PCR products were visu-
alized by agarose gel electrophoresis and purified through
silica-base chromatography in a Tecan liquid handler
(Switzerland). Purified PCR products were cloned into
pHTP1 expression vector (NZYTech, Ltd) using the
NZYEasy cloning kit (NZYTech, Ltd) that follows a LIC
technology. Gene assembly products were mixed with
120 ng of linearized vector, using a molar ratio of 1:5 (vec-
tor:insert). Cloning reactions were performed in 10 μL
volume in a 96-well PCR plate and preceded for 1 h at
37 °C on a heating block. The mixtures were then incu-
bated at 80 °C for 10 min followed by 10 min at 30 °C.
Recombinant plasmids were transformed using a high-
throughput method into E. coli DH5α competent cells
and spread on LB agar plates supplemented with
50 μg/mL of kanamycin. After overnight incubation at
37 °C, only one colony per transformation was picked and
grown in 5 mL of LB kanamycin medium in 24-deep-well
plates sealed with gas-permeable adhesive seals. Cultures
were incubated at 37 °C for ~16 h and cells were then
harvested at 1,500 × g for 15 min. Plasmids were purified
from bacterial pellets in a Tecan workstation (Switzerland),
and subsequently the DNA sequence of each gene was
verified by Sanger sequencing. In case the DNA sequence
did not correspond with the designed gene, a second and
eventually third colony was picked for sequencing analysis.
Results and discussion
Synthesis and assembly of the 213 nt gene encoding alpha-
elapitoxin-Nk2a toxin using PCA-DT and PCA-DTF methods
The gene encoding the toxic peptide alpha-elapitoxin-
Nk2a was designed to maximize expression in E. coli. Initial
experiments aimed at identifying the most appropriate
strategy for the synthesis of small genes and attempted to
reduce the number of steps involved in traditional gene
synthesis approaches. Thus, the efficiency of PCA-DT and
PCA-DTF PCR-based methods was tested for the synthesis
of gene A, which has a size of 290 nt (Fig. 1). To ensure
simplicity and speed in the synthetic gene process, PCA-
DT does not involve an additional cloning step. Using
method A1 (Fig. 1), gene A was synthesised using pNZY28
vector as DNA template and employing two long oligonu-
cleotides (135 nt) to amplify the full-length plasmid se-
quence containing half of the gene sequence in each 5’ and
3’ ends. Long oligonucleotides are more prone to incorpor-
ate errors. Thus, in alternative, gene A was also amplified
using a set of 14 and 12 overlapping oligonucleotides (Fig. 1,
strategies A2 and A3, respectively), which contain a 20 nt
sequence that hybridises with the cloning plasmid. In con-
trast, PCA-DTF methods use a template-less approach to
assemble the artificial gene. The six methods described in
Fig. 1 were employed to synthesize gene A. The data,
a b c
Fig. 2 The efficacy of PCA-DT and PCA-DTF methodologies to generate small nucleic acids. Panel a: synthesis of gene A was performed using a vector
DNA template (A1, A2 and A3) and the PCR products correspond to a 3,099 bp DNA fragment, which combines gene A sequence plus pNZY28 vector
sequence. b: gene A was also assembled using different pools of overlapping oligonucleotides (B1, B2 and B3); lane C− corresponds to a negative control
reaction performed at the same conditions, without addition of primers. c: Effect of primer design on percentage of clones without errors. M1: NZYLadder
III, M2: NZYLadder I
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presented in Fig. 2, revealed that all strategies effectively
generated the toxic gene. However, yield of the assembled
target nucleic acid was higher using strategies B when com-
pared with the quantity of PCR product obtained using the
PCA-DT. Although strategy A does not require an add-
itional step to insert the synthetic gene into the cloning
plasmid, globally the process is more tedious due to the
long periods required for the amplification of large nucleic
acids, as PCR involves both the toxic gene and the vector
(~3 Kb, pNZY28 vector plus target gene). In addition, clon-
ing efficiency, evaluated through colony-PCR, revealed an
approximately 95% cloning efficacy of the Gateway system
versus 80% when using the self-ligation process of strategy
A. These results suggest that strategies including a DNA
template and involving plasmid re-circularization are prob-
ably not the best option for the synthesis of small genes as
they are more tedious while leading to lower cloning effi-
ciencies. These two issues are particularly important when
protocols require automation.
In order to verify if the length of the oligonucleotides in-
fluences the appearance of errors in synthetic genes, we se-
lected 24 clones synthesized by strategies B1, B2 and B3 for
DNA sequence verification using Sanger sequencing. Ana-
lysis of the 72 sequences revealed that approximately 80%
of the clones for each one of the three strategies presented
the correct DNA sequence (Fig. 2c). Thus, increasing pri-
mer size from 40 to 60 nt has no impact in the number of
errors in the resulting synthetic DNA. This primer size was
also used by Stemmer and colleagues to successfully syn-
thesise two long DNA fragments [4], although the error
rate associated with the method was not reported. There-
fore, taken together, the data suggest that the PCA-DTF
gene assembly method that uses a set of 60 nt overlapping
oligonucleotides with 20 nt gaps, is the most convenient
strategy for the synthesis of small genes as it provides high
gene synthesis yields and efficacy with increased cloning
efficiencies.
Performance of various thermostable DNA polymerases
for gene synthesis
Taq, Kod and Pfu polymerases have been commonly used
for the production of synthetic genes following PCR-based
methods [4, 7, 13]. However, Taq polymerase is known to
be error-prone [14]. The use of Kod and Pfu polymerases
allow higher accuracy in gene synthesis although the
elongation rate of Pfu polymerases is lower [15]. Here, the
efficacy of four different DNA polymerases (KOD Hot
Start DNA polymerase, Q5® Hot Start HF, Pfu Turbo
DNA polymerase, and Taq DNA polymerase) for the pro-
duction of gene B (260 bp), using B3 strategy PCA-DTF
(described above) was analysed. The data, presented in
Fig. 3, revealed that the four polymerases effectively as-
sembled the 260 bp gene. However, KOD Hot Star DNA
polymerase seems to express a higher performance when
compared with the other enzymes. These data suggest that
efficacy of Kod polymerases is higher than Taq and Pfu en-
zymes for assembling small genes. After cleaning the PCR
products, genes were cloned into pDONR201 vector and
24 clones assembled by each one of the four DNA poly-
merase were sequenced. The data, presented in Table 2,
Fig. 3 Performance of four thermostable DNA polymerases for the
synthesis of gene B using PCA-DTF. Lane 1: negative control reaction
performed at the same conditions, without addition of primers; lane
2: KOD Hot Start DNA polymerase; lane 3: Q5 Hot Start High Fidelity
DNA polymerase; lane 4: Pfu Turbo DNA polymerase and lane 5: Taq
DNA polymerase. M2: NZYladder I



















KOD HS DNA pol. yes 24 5720 5 0.87 2 1 2
Q5® HS HF DNA pol. yes 24 6240 10 1.6 6 1 3
NZYProof DNA pol. no 24 6240 10 1.6 5 2 3
NZYTaq DNA pol. no 24 5980 13 2.2 2 3 7
Total 96 24,180 38 15 7 15
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revealed that appearance of mutations is more frequent
for Taq, followed by Q5® Hot Start HF and Pfu Turbo
DNA polymerase. In contrast, only five out of the 22 re-
combinant plasmids containing the synthetic gene B as-
sembled by KOD Hot Star DNA polymerase presented
errors, which reflects one mutation per 1.15 kb. Deletions
and substitutions were the most frequent errors identified
in the 96 variants of gene B sequenced. As expected, the
data suggested that KOD Hot Start DNA polymerase is
more accurate than the other three DNA polymerases due
to a higher fidelity. These results are in line with previous
studies [8, 9, 16], which have revealed that usage of high
fidelity DNA polymerases decreases the number of errors
introduced in synthetic genes during PCR amplification.
Moreover, the PCA-DTF procedure appears to be very ef-
ficient with KOD Hot Start DNA polymerase due to the
rapid elongation rates presented by this DNA polymerase;
completion of the gene synthesis protocol is achieved in
less than 40 min.
Oligonucleotide concentration influences the efficacy of
gene synthesis
Since PCA-DTF is suggested to be the best method
to produce small synthetic genes and KOD Hot Star
DNA polymerase is the most effective enzyme to
apply in these protocols, we analysed the influence of
a
b
Fig. 4 Influence of oligonucleotide concentration in the efficacy of the assembly reaction. a: PCR assembly was performed with 200, 600 and 1000 nM
of outer oligonucleotides using 0.2 or 0.4 mM dNTPs and 10 nM or 30 nM of inner primers. A control reaction containing no primers was performed
under same conditions (outer primers concentration:1000 nM and 0.4 mM of dNTPs). b: Outer primers concentration was fixed to 800 nM and inner
primer concentration varied between 10 to 30 nM. Lanes 1–5 correspond to: 0.1, 0.2, 0.3, 0.4 and 0.5 mM dNTPs. M1: NZYLadder III; M2: NZYLadder I
a b
Fig. 5 Effect of cycling temperatures on the efficiency of gene synthesis. Panel a: different annealing temperatures were studied (1: 50 °C; 2:
52.3 °C; 3: 54.6 °C; 4: 59.6 °C and 5: 62 °C). Panel b: 22, 24 and 26 cycles combined with different times of denaturation, annealing and extension
were used to synthesise gene C (I: 95 °C for 20 s, 60 °C for 10 s, 70 °C for 1 s; II: 95 °C for 16 s, 60 °C for 10 s, 70 °C for 1 s; III: 95 °C for 20 s, 60 °C
for 8 s, 70 °C for 1 s; IV: 95 °C for 16 s, 60 °C for 8 s, 70 °C for 1 s; V: 95 °C for 20 s, 60 °C for 10 s, 70 °C for 3 s; VI: 95 °C for 16 s, 60 °C for 10 s,
70 °C for 3 s; VII: 95 °C for 20 s, 60 °C for 8 s, 70 °C for 3 s; VIII: 95 °C for 16 s, 60 °C for 8 s, 70 °C for 3 s). The extension times used for each
number of cycles were 1 and 3 s
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oligonucleotide concentration on gene assembly effi-
ciency. Thus, three different concentrations of inner
oligonucleotides were combined with different
concentrations of outer primers in a PCR-assembly
reaction set to synthesize gene B. Initially, concentra-
tions of inner oligonucleotides were of 10 nM and 30
nM, and outer oligonucleotides were tested at 200,
600 and 1000 nM. After the assembly of gene B the
resulting nucleic acids were analysed by agarose gel
electrophoresis. The data, presented in Fig. 4a, sug-
gest that gene synthesis is most effective with 30 nM
of inner primers. In addition, the best concentrations
of outer primers were of 600 and 1000 nM. In order
to define more precisely the best concentrations of
primers, outer primer concentration was fixed at 800
nM and concentrations of inner primers varied from
10 to 30 nM. Data suggest that at 800 nM of outer
primers, the optimal concentration of inner oligonu-
cleotides is 20 nM (Fig. 4b). The assembly reaction
was also performed under different concentrations of
dNTPs. Interestingly, the results suggest that concen-
trations of dNTPs below 0.2 mM are not appropriate
for gene synthesis. Thus, for a robust and successful
PCA-DTF procedure a concentration of 0.3–0.4 mM
of dNTPs seems to be the most effective (Fig. 4).
Effect of cycling temperatures on the efficiency of gene
synthesis
In the previous assembly reactions following PCA-DTF, an-
nealing temperature was set to 60 °C. Several studies [3]
have suggested that factors such as melting temperature
(Tm) and GC content affect optimal assembly. Thus, the ef-
ficiency of synthesis of gene B was tested using a gradient
of annealing temperatures (50 °C, 52.3 °C, 54.6 °C, 59.6 °C
and 62 °C) applying the optimal PCR conditions described
in the previous section. The data, presented in Fig. 5, sug-
gest that oligonucleotide assembly occurs at temperatures
ranging from 50 to 62 °C, although yields of nucleic acid
seems to increase at higher annealing temperatures. In
addition, the effect of the number of PCR cycles in the effi-
ciency of gene synthesis was tested by synthesizing gene C
using 22, 24 and 26 thermal cycles. The data revealed that,
as expected, the quantity of the amplified product increases
with the number of thermal cycles employed (Fig. 5). Like-
wise, when denaturation last 20 s, an extension of 3 s pro-
duces higher DNA yields than a 1 s extension. In addition,
annealing of overlapping oligonucleotides during 8 s is
more favourable than for 10 s. Therefore, the data revealed
that 26 thermal cycles of denaturation (20 s), annealing
(8 s) and extension (3 s) step are optimal for PCR assembly
following the PCA-DTF method.
Effect of oligonucleotide source in the efficacy of gene
synthesis
It is well known that efficacy of gene synthesis directly
depends on the quality of the synthetic oligonucleotides
used for DNA assembly [17]. Current chemical synthesis
methods usually produce oligonucleotides that are
prematurely terminated or comprise internal insertions
Fig. 6 Assembly of gene C using oligonucleotides obtained from three
different suppliers (A, B and C) and three purification methods. Numbers
correspond to desalted (1), reverse-phase cartridge (2) and HPLC (3)
primers purification methods. Lane 1 corresponds to a negative control
reaction performed without addition of oligonucleotides
Table 3 Oligonucleotides purification and source used to assembly the gene C
Oligonucleotide
source














A1 A desalted 16 68% 6 4 1 1
B1 B desalted 16 80% 3 2 0 1
C1 C desalted 16 71% 7 3 2 2
C2 C cartridge 16 50% 14 4 5 5
C3 C HPLC 16 56% 11 5 4 2
Total 80 41 18 (18/41 = 44%) 12 (12/41 = 29%) 11 (11/41 = 27%)
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or deletions [17]. To determine how the oligonucleotide
source modulates the production of error-free DNA
fragments, gene C was synthesised using desalted,
reverse-phase cartridge and reverse-phase HPLC puri-
fied primers obtained from three different suppliers.
Gene C was assembled using PCR conditions defined
above and five different oligonucleotide sources were
analysed. The results, presented in Fig. 6, show that
oligonucleotides from supplier B displayed the best per-
formance. DNA plasmids of 16 recombinant clones for
each condition were analysed by Sanger sequencing. The
highest percentage of clones without errors was identified
in genes synthesized with primers for supplier B which
were not subjected to any purification (Table 3). PCR
products assembled using reverse-phase cartridge and
HPLC oligonucleotides have a lower percentage of clones
without errors (B2 - 50% and B3 - 56%, respectively) when
compared with exclusively desalted oligonucleotides.
Thus, it is noteworthy observing that oligonucleotide puri-
fication does not solve the percentage of mutation ob-
served in artificial genes. The most frequent mutation
identified in the 80 recombinant clones was a single base
deletion (44%, see Table 3 and Additional file 6: Table S6).
These results suggest that truncated versions of the oligo-
nucleotides (n-1) are difficult to remove by accessory puri-
fication methods as the desalted oligonucleotides from
supplier B contain a lower frequency of deletions. In
contrast, previous studies have shown that PAGE oligo-
nucleotide purification is recommended for the successful
production of synthetic genes by PCR assembly [8, 13, 16,
18]. However, the error rates reported in these studies is
identical (~1 error per Kb of synthetic DNA) to our gene
synthesis method revealing that oligonucleotide purification
is not crucial for the accurate production of DNA frag-
ments. In our high-throughput study, the purification of
oligonucleotides can be a disadvantage since the production
cost would significantly increase.
Large scale synthesis of genes encoding venom peptides
using an automated platform
Previous optimized protocols were used to develop a
platform for the simultaneous synthesis of small genes.
Thus, the primary sequence of 96 venom peptides was
used to design 96 genes that contained an average GC
content of 49% and an average CAI of 0.86 (Table 4). To
assemble the 96 genes, 576 (6 primers × 96 genes) oligo-
nucleotides with a maximum of 60 nt were designed
with an overlap region of 20 bp and a gap of 20 bp. In
average, the genes had 240 bp in length and oligonucleo-
tides were acquired without additional purification. Each
gene was PCR assembled using the KOD Hot Start DNA
polymerase. Outer primers were used at 800 nM (for-
ward and reverse) while inner primers at a final concen-
tration of 20 nM. PCR assembly was performed in
26 cycles of 95 °C for 20 s, 60 °C for 8 s and 3 s at 70 °C.
The 96 genes were assembled simultaneously in a 96-
well PCR plate and resulting nucleic acids analysed
through agarose gel electrophoresis. The data, presented
in Fig. 7, revealed that 94 out of the 96 genes were
effectively assembled representing a 98% success rate of
the gene synthesis protocol when applied to a large scale.
After purification of the 96 generated PCR products, indi-
vidual genes were sub-cloned into pHTP1 expression vec-
tor using a LIC method. The robustness and effectiveness
Table 4 Properties of 96 optimized genes that were
synthesised using the HTP gene synthesis platform
Length (nt) GC content (%) Codon adaptation
index (CAI)
Mean (±SD) 240 ± 9 48.9 ± 3.4 0.86 ± 0.03
Maximum 254 57 0.97
Minimum 215 40 0.80
Fig. 7 Agarose gel electrophoresis of 96 nucleic acids encoding venom peptides assembled simultaneously using a large scale gene synthesis
platform. 98% of gene products presented high yield and correct size. 2 out the 96 genes (3 and 52) showed PCR fragments with low yield. However, the
96 PCR products were used for subsequent cloning reaction and resulting plasmids were employed to transform E. coli cells. Resulting recombinant
plasmids were purified and the integrity of DNA sequences was verified by Sanger sequencing
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of the pipeline was demonstrated when recombinant plas-
mids were sequenced to verify gene integrity. The initial
screen of one clone per gene revealed that 77 genes
(80.2%) were correct (Table 5). For 17 genes (17.7%) two
clones were screened to identify an error-free DNA frag-
ment. Finally, for 2 genes (2.1%) it was necessary to pick a
third clone to obtain a correct DNA sequence. Thus, even
for the two genes that apparently were amplified at a
lower concentration it was possible to obtain a correct
clone. In total, 26 mutations were identified in incorrect
genes, leading to an overall error rate of 1 mutation per
0.9 kb. The majority of the identified mutations were
deletions (77%), as it is expected from the incorporation
of prematurely terminated oligonucleotide [19]. The
remaining mutations were single-base substitutions (19%)
and insertions (4%).
There are some major differences between the ap-
proach and resulting efficacy of the method reported
here when compared with previously described proto-
cols (Table 6). Firstly, some of the reported gene
synthesis methods involve usage of oligonucleotides
subjected to subsequent downstream purifications (see
Table 6). The protocol described here uses desalted oligo-
nucleotides (no purification) to accurately produce differ-
ent DNA fragments. Since price of non-purified
oligonucleotides is reduced, the cost associated with the
method described here is lower, which represents a strong
advantage for both low and high-throughput protocols.
Secondly, this method uses 60-bp oligonucleotides while
some reported methods use oligonucleotides with a length
below 60 bases. Thus, the number of oligonucleotides re-
quired for each assembly reaction using the protocol de-
scribed here is significantly reduced while maintaining the
success rate of gene synthesis. Although large primers can
incorporate more errors, data reported here show that the
increase of oligonucleotide size from 40 to 60 bp had no
impact in the percentage of correct synthesised DNA se-
quences. Thus, for the protocol reported here, the use of
60-bp oligonucleotides is believed to provide the best bal-
ance between error rate and production cost. Finally, the
error rate observed in the gene synthesis method reported
here is lower or identical to previously reported methods
(Table 6), revealing that this platform is efficient and ro-
bust to synthesise multiple genes in simultaneous.
Table 5 Properties of primers used in gene synthesis of 96 genes encoding venom peptides. Error rate determined for the











































96 6 57–60 20 23,058 26 1.13 20 1 5 77 17 2
Table 6 Comparison of different methods used to produce synthetic DNA fragments






















Single step: assembly PCR 40 20 NM No
purification
Taq NM [4]
2004 PTDS Two steps: Assembly PCR & Overlap
extension PCR





Two steps: Dual asymmetric PCR &
Overlap extension PCR
50 10 NM No
purification
Pfu 3/4 clones contain 1–3 single
base deletions
[7]
2006 PAS Two steps: Assembly PCR & Overlap
extension PCR
60 21 NM PAGE Pfu ~1 [18]
2006 SGS Single step: assembly PCR 40 18–20 No No
purification
Kod 2.7 [9]




15 NM PAGE Pfu 1 [8]
2012 AOE Two steps: Assembly PCR & Overlap
extension PCR
30–50 NM NM PAGE Pfu <1 [19]
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Conclusions
The ability to de novo synthesize DNA sequences is
rapidly emerging to improve the speed, accuracy and
simplicity of recombinant DNA technology. Here, we
have optimized a novel gene synthesis large scale plat-
form for the efficient production of small genes
(<0,5 kb). The genes were directly cloned into an E. coli
expression vector using a completely automated proto-
col. This gene synthesis approach presents high effi-
ciencies of PCR assembly and cloning while revealing
low error rates. The error rate of the large scale method
described here is of 1.1 mutations per kb. Low error
rates avoid additional steps for the removal of errors
from synthesized genes, such as those involving the use
of proteins that recognize mismatches within DNA
sequences to remove DNA mutations. The identifica-
tion of 100% correct genes was performed by screening
a maximum of 3 colonies. Thus, the labour required for
the selection and validation of recombinant clones is
reduced. The use of overlapping oligonucleotides com-
bined with Kod DNA polymerase provides a powerful
alternative to conventional synthesis protocols. The
length of all oligonucleotides is below 60 nt, with 20-bp
overlap regions and gaps of 20 nt. This represents a
decrease in the number of oligonucleotides for a given
gene saving costs. The PCR-based gene synthesis
method described here is an optimization of the simpli-
fied gene synthesis method (SGS) [9]. However, among
other details, average primer lengths in the protocol
described in this study is larger than used in SGS
methods. In conclusion, the gene synthesis approach
described here is a simple, accurate and robust system
that can be used to construct at low cost and in short
periods of time large numbers of de novo DNA mole-
cules for a variety of applications.
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